Viromed Medical AG (Q11) — Long-term Investment Intensity
Viromed Medical AG (Q11) has a Long-term Investment Intensity of 3.9% as of September 2025. Long-term investments of €13.15 Million represent 3.9% of total assets of €339.03 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Viromed Medical AG for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Viromed Medical AG Long-term Investment Intensity (2023–2024)
This chart shows how Viromed Medical AG's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of September 2025, the intensity stands at 3.9%, reflecting long-term investments of €13.15 Million against total assets of €339.03 Million EUR. Also explore Q11 total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Viromed Medical AG (2023–2024)
The table below presents the year-by-year Long-term Investment Intensity for Viromed Medical AG from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Viromed Medical AG worth.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 8.4% | €21.60 Million | €255.98 Million | ▼ -16.8 pp |
| 2023 | 25.2% | €27.01 Million | €107.24 Million | — |